Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Assets ratio high or low?
The EV/Assets ratio of 2.54x is in line with its estimated 1-year average of 2.79x, near the low end of its estimated 1-year range (2.50x–3.12x).
As of 2026-10-06T18:47:54.877Z.
Calculation as of: 2026-10-06T18:47:54.877Z.
Quote observation: 2026-10-06T18:44:35.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 77ffd79d43f0055242b38282a97f53e69ef3ec7586b4a3f7de15a7f16befe37a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
2.54x
EV/ASSETS RATIO AVG TTM
N/A
EV/ASSETS RATIO AVG 3Y
N/A
EV/ASSETS RATIO AVG 5Y
N/A
EV/ASSETS RATIO AVG 10Y
N/A
EV/ASSETS RATIO AVG 15Y
N/A
EV/ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+60.76%
vs the sector median at left
SpyGlass Pharma, Inc. Common Stock
Market Cap
$840.68M
EV/Assets Ratio
2.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$842.16M
EV/Assets Ratio
0.66x
TTM Avg
0.71x
3Y Avg
0.74x
5Y Avg
0.94x
Market Cap
$838.58M
EV/Assets Ratio
2.74x
TTM Avg
2.38x
3Y Avg
2.31x
5Y Avg
2.31x
Market Cap
$843.28M
EV/Assets Ratio
1.98x
TTM Avg
1.47x
3Y Avg
1.19x
5Y Avg
1.39x
Market Cap
$835.44M
EV/Assets Ratio
1.13x
TTM Avg
2.03x
3Y Avg
1.33x
5Y Avg
1.18x
Market Cap
$857.96M
EV/Assets Ratio
304.18x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$863.17M
EV/Assets Ratio
1.62x
TTM Avg
2.07x
3Y Avg
2.15x
5Y Avg
2.13x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. Common Stock (SGP) | $840.68M | 2.54x | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $842.16M | 0.66x | 0.71x | 0.74x | 0.94x |
| Beta Bionics, Inc. (BBNX)vs › | $838.58M | 2.74x | 2.38x | 2.31x | 2.31x |
| Alumis Inc. (ALMS)vs › | $838.72M | 1.45x | 3.92x | 2.29x | 2.29x |
| Pacific Biosciences of California, Inc. (PACB)vs › | $843.28M | 1.98x | 1.47x | 1.19x | 1.39x |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $835.44M | 1.13x | 2.03x | 1.33x | 1.18x |
| SI-BONE, Inc. (SIBN)vs › | $856.52M | 3.34x | 2.94x | 2.91x | 3.27x |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | 304.18x | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.17M | 1.62x | 2.07x | 2.15x | 2.13x |
| Ardelyx, Inc. (ARDX)vs › | $812.73M | 1.69x | 3.04x | 3.76x | 3.03x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/ASSETS RATIO |
|---|---|
| 2026-10-05 | 2.61x |
| 2026-10-02 | 2.51x |
| 2026-10-01 | 2.73x |
| 2026-09-30 | 2.66x |
| 2026-09-29 | 2.58x |
| 2026-09-28 | 2.66x |
| 2026-09-25 | 2.81x |
| 2026-09-24 | 2.89x |
| 2026-09-23 | 2.96x |
| 2026-09-22 | 3.03x |
| 2026-09-21 | 2.93x |
| 2026-09-18 | 3.08x |
| 2026-09-17 | 3.12x |
| 2026-09-16 | 3.02x |
| 2026-09-15 | 3.07x |
| 2026-09-14 | 3.03x |
| 2026-09-11 | 2.87x |
| 2026-09-10 | 2.84x |
| 2026-09-09 | 2.87x |
| 2026-09-08 | 3.06x |
| 2026-09-04 | 3.07x |
| 2026-09-03 | 3.07x |
| 2026-09-02 | 2.97x |
| 2026-09-01 | 2.78x |
| 2026-08-31 | 2.68x |
| 2026-08-28 | 2.72x |
| 2026-08-27 | 2.79x |
| 2026-08-26 | 2.75x |
| 2026-08-25 | 2.74x |
| 2026-08-24 | 2.70x |
| 2026-08-21 | 2.73x |
| 2026-08-20 | 2.69x |
| 2026-08-19 | 2.83x |
| 2026-08-18 | 2.64x |
| 2026-08-17 | 2.63x |
| 2026-08-14 | 2.69x |
| 2026-08-13 | 2.55x |
| 2026-08-12 | 2.56x |
| 2026-08-11 | 2.50x |
| 2026-08-10 | 2.55x |
| 2026-08-07 | 2.57x |
